Bradley L. Campbell, President and CEO at AMICUS THERAPEUTICS, INC. (FOLD), sold 31,666 shares at $12.56 ($398K) on 2024-02-01, disclosed to the SEC on 2024-02-05.
Scheduled sale ($398k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.56 | 15,833 | $199K | 50.0% |
| 2 | $12.56 | 15,833 | $199K | 50.0% |
| Total | $12.56 avg | 31,666 | $398K | 100% |
| Filing → |
| FOLD | SELL | 2025-12-17 | $1.7M | — | Filing → |
| FOLD | SELL | 2025-12-03 | $292K | — | Filing → |
| FOLD | SELL | 2025-11-26 | $293K | — | Filing → |